Concepedia

Suresh Giri

SG

Statistics

Publications

15

Citations

792

H-Index

14

Active since

2008

Affiliations

Zydus Lifesciences Limited (India)(Current)

Maharaja Sayajirao University of Baroda

JSS Academy of Higher Education and Research

Armed Forces Medical College

Indian Institute of Chemical Biology

Suresh Giri is an author at Zydus Lifesciences Limited (India) specializing in pharmacology, medicinal chemistry, and molecular pharmacology.

ORCID

Publications per year

2008–2023

15

Publications

15

Dual <scp>PPAR</scp>α/γ agonist saroglitazar improves liver histopathology and biochemistry in experimental <scp>NASH</scp> models

Mukul R. Jain, Suresh Giri, Bibhuti Bhoi et al. · Liver International · 2017 · 201 citations · Full text

, , +17

Melatonin protects against lipid‐induced mitochondrial dysfunction in hepatocytes and inhibits stellate cell activation during hepatic fibrosis in mice

Nabanita Das, Ashok Mandala, Shamreen Naaz et al. · Journal of Pineal Research · 2017 · 155 citations

, , +17

The PPAR α/γ Agonist Saroglitazar Improves Insulin Resistance and Steatohepatitis in a Diet Induced Animal Model of Nonalcoholic Fatty Liver Disease

Divya P. Kumar, Rebecca Caffrey, Jonathon Marioneaux et al. · Scientific Reports · 2020 · 108 citations · Full text

, , +15

Saroglitazar, a novel PPAR<i>α</i>/<i>γ</i> agonist with predominant PPAR<i>α</i> activity, shows lipid‐lowering and insulin‐sensitizing effects in preclinical models

Mukul R. Jain, Suresh Giri, Chitrang Trivedi et al. · Pharmacology Research & Perspectives · 2015 · 95 citations · Full text

, , +13

Effect of saponins from Helicteres isora on lipid and glucose metabolism regulating genes expression

Shefalee K. Bhavsar, Satinder Singh, Suresh Giri et al. · Journal of Ethnopharmacology · 2009 · 41 citations

, , +11

1–5 of 15